Healthpeak Properties/$DOC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Healthpeak Properties
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
- Ticker
- $DOC
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 411
- Headquarters
- Denver, United States
- Website
- www.healthpeak.com
DOC Metrics
BasicAdvanced
$13B
55.22
$0.34
0.99
$1.22
6.41%
Price and volume
Market cap
$13B
Beta
0.99
52-week high
$22.95
52-week low
$15.70
Average daily volume
5.9M
Dividend rate
$1.22
Financial strength
Current ratio
0.827
Quick ratio
1.928
Long term debt to equity
1.008
Total debt to equity
1.087
Dividend payout ratio (TTM)
347.72%
Interest coverage (TTM)
1.47%
Profitability
EBITDA (TTM)
1,561.053
Gross margin (TTM)
57.46%
Net profit margin (TTM)
8.25%
Operating margin (TTM)
16.84%
Effective tax rate (TTM)
1.32%
Revenue per employee (TTM)
$7,180,000
Management effectiveness
Return on assets (TTM)
1.51%
Return on equity (TTM)
3.04%
Valuation
Price to earnings (TTM)
55.22
Price to revenue (TTM)
4.475
Price to book
1.67
Price to tangible book (TTM)
1.86
Price to free cash flow (TTM)
10.724
Free cash flow yield (TTM)
9.32%
Free cash flow per share (TTM)
1.775
Dividend yield (TTM)
6.41%
Forward dividend yield
6.41%
Growth
Revenue change (TTM)
5.52%
Earnings per share change (TTM)
46.76%
3-year revenue growth (CAGR)
11.71%
10-year revenue growth (CAGR)
5.18%
3-year earnings per share growth (CAGR)
-29.01%
10-year earnings per share growth (CAGR)
9.28%
3-year dividend per share growth (CAGR)
0.55%
10-year dividend per share growth (CAGR)
-6.06%
What the Analysts think about DOC
Analyst ratings (Buy, Hold, Sell) for Healthpeak Properties stock.
Analyst projections of the future price of Healthpeak Properties stock.
Bulls say / Bears say
Healthpeak raised its 2026 adjusted FFO guidance to $1.73–$1.77 per share and lifted its same-store NOI growth outlook, signalling better earnings expectations across the portfolio. (Nasdaq)
Outpatient medical leasing remains firm: Healthpeak reported 5% cash re-leasing spreads, 80% tenant retention and occupancy of 90.7%, up 20 basis points sequentially. That gives its largest business a solid base for rental growth. (The Motley Fool)
Janus Living is a fast-growing contributor to Healthpeak, which retained a 73.6% stake after the senior-housing business went public. In the second quarter, Janus reported 19% same-store NOI growth and 45% revenue growth. (The Motley Fool)
Life-science remains a drag: lab occupancy was only 78.5%, while same-store NOI fell 3.2% year on year. A prolonged recovery could hold back growth across the wider portfolio. (Nasdaq)
Debt makes new investment harder to justify while financing is costly. Healthpeak reported net debt to adjusted EBITDA of 4.7 times, and management said borrowing costs were not much below the cap rates on its properties. (The Motley Fool)
The latest FFO guidance increase was modest, and management said part of it came from recognising interest amortisation after a seller-loan repayment. That source of earnings is less repeatable than rent and occupancy growth. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.
DOC Financial Performance
Revenues and expenses
DOC Earnings Performance
Company profitability
Upcoming events
DOC News
AllArticlesVideos
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
Business Wire4 weeks ago
Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast
Business Wire4 weeks ago
With REIT, Investors Don't Have to Write Off REITs
ETF Trends1 month ago
Funds containing DOC
AllUSDEURGBP
Fund name | Fund size | $DOC weighting |
|---|---|---|
Invesco S&P 500 High Dividend Low Volatility£HDLG | $456M | 2.26% |
Invesco S&P 500 High Dividend Low Volatility$HDLV | $456M | 2.26% |
Invesco Real Estate S&P US Select Sector$XRES | $150M | 1.20% |
Invesco Real Estate S&P US Select Sector£XREP | $150M | 1.20% |
VanEck Global Real Estate€TRET | €448M | 0.97% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.